Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.

Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.

Item
http://www.wikidata.org/entity/Q33174652
Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focusA 6-month large-scale study into the safety of tamsulosinComparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysisTamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy.Medical treatment of benign prostatic hyperplasia.Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study.Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.itBenign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management.Effects of low-dose tamsulosin on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasiaMeasurement of benign prostatic hyperplasia treatment effects on male sexual function.Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosinProphylactic urethral stenting with Memokath® 028SW in prostate cancer patients undergoing prostate 125I seed implants: phase I/II studyDifferential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin.
P2860

Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.

Item
http://www.wikidata.org/entity/Q33174652
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Tamsulosin, the first prostate ...... ropean Tamsulosin Study Group.
@ast
Tamsulosin, the first prostate ...... ropean Tamsulosin Study Group.
@en
type
label
Tamsulosin, the first prostate ...... ropean Tamsulosin Study Group.
@ast
Tamsulosin, the first prostate ...... ropean Tamsulosin Study Group.
@en
prefLabel
Tamsulosin, the first prostate ...... ropean Tamsulosin Study Group.
@ast
Tamsulosin, the first prostate ...... ropean Tamsulosin Study Group.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
Tamsulosin, the first prostate ...... ropean Tamsulosin Study Group.
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921